Zobrazeno 1 - 10
of 11
pro vyhledávání: '"329"'
Autor:
U. Creutzig, P. Smisek, L. Hovi, B. Stark, B. Gibson, B. Razzouk, Carmelo Rizzari, R. Tamminga, G.J.L. Kaspers, A. Baruchel, S. Ha, D. Reinhardt, Y. Bertrand, M. Zimmermann, H. Armendariz, Alexei Maschan, M. Dworzak, O. Smith
Publikováno v:
Blood. 112:2977-2977
Relapse remains the commonest adverse event in newly diagnosed AML patients, and the reported long-term survival after relapse in pediatric AML is 20–30%. Allogeneic stem cell transplantation (allo-SCT) in CR1 is employed by several groups with the
Autor:
Evandro D. Bezerra, Brenda M. Sandmaier, Linde M. Morsink, Megan Othus, H. Joachim Deeg, H. Gary Schoch, Brent L. Wood, Min Fang, Frederick R. Appelbaum, Roland B. Walter
Publikováno v:
Blood. 134:321-321
Background:Myeloablative allogeneic hematopoietic cell transplantation (HCT) is a common post-remission treatment strategy for medically fit adults with acute myeloid leukemia (AML) in morphologic remission. Several conditioning regimens have been ut
Autor:
Yuan-Shung Huang, Brian T. Fisher, Richard Aplenc, Karen R. Rabin, Kelly D. Getz, Jennifer J. Wilkes, Viviane C. Cahen, Yimei Li, Lena E. Winestone, Amanda M. DiNofia, M. Monica Gramatges, Alix E. Seif, Caitlin W Elgarten
Publikováno v:
Blood. 132:624-624
Administrative databases can be used to study outcomes including patients outside of clinical trials and have been used to identify relapse and HSCT in adult and adolescent/young adult leukemia populations. However, there are no published studies usi
Autor:
Pablo J. Muxi, Bjorn Andreasson, Peter L. Johansson, Robyn M. Scherber, Dana Ranta, Stefanie Slot, Heidi E. Kosiorek, Dolores Hernández-Maraver, Amylou C. Dueck, Xiujuan Sun, Martin Griesshammer, Ana Kerguelen Fuentes, Peihong Zhang, Francesco Passamonti, Holly L. Geyer, Federico Sackmann, Zefeng Xu, Gabriel Etienne, Deepti Radia, Frank Stegelmann, Andreas Reiter, Tiziano Barbui, Jean-Christophe Ianotto, Suzan Commandeur, Peter A. W. te Boekhorst, Zhijian Xiao, Sonja Zweegman, Harry C. Schouten, Gunnar Birgegård, Carlos Besses, Françoise Boyer, Giovanni Barosi, Ruben A. Mesa, Alessandro Rambaldi, Jean-Jacques Kiladjian, Maria Grazia Ferrari, Thomas Lehmann, Heike L. Pahl, Lydia Roy, Jan Samuelsson, Francisco Cervantes, Alessandro M. Vannucchi, Konstanze Döhner, Yue Zhang, Karin Bonatz, Junqing Xu, Robert Peter Gale, Norman Maldonado, Jean-Yves Cahn, Claire N. Harrison
Publikováno v:
Blood. 126:4080-4080
Background Myelofibrosis (MF) is a clonal myeloproliferative neoplasm (MPN) associated with a high degree of symptomatology, progressive cytopenias and potential to transform into acute myelogenous leukemia (AML). Thrombocytopenia amongst MF patients
Autor:
Jennifer S. Temel, Tanya Keenan, Yi-Bin Chen, Harry VanDusen, Areej El-Jawahri, Daniel J. DeAngelo, Amir T. Fathi, Thomas W. LeBlanc, Philip C. Amrein, David P. Steensma, Lara Traeger, Richard Stone, Karen K. Ballen, Martha Wadleigh, Gregory A. Abel, Gabriela S. Hobbs
Publikováno v:
Blood. 126:2104-2104
Introduction: Older adults (≥ 60 years) with acute myeloid leukemia (AML) generally have a poor prognosis and a high rate of health care utilization including intensive care unit (ICU) admissions. While the outcomes of older patients with advanced
Publikováno v:
Blood. 124:4856-4856
Background: Health services and outcomes research in sickle cell disease (SCD) has been limited by inadequate population-based surveillance and reliance on ICD-9 codes to identify individuals with SCD. The accuracy of ICD-9 coding in administrative c
Autor:
Kara Cetin, Michelle Gleeson, Robert I. Griffiths, Aaron J. Katz, Michael A. Kelsh, Mark D. Danese
Publikováno v:
Blood. 122:3877-3877
Background ALL is the most common childhood cancer, with remission rates exceeding 90% and 5-year survival exceeding 80% in pediatric patients. However, in older adult patients, ALL is associated with high morbidity and mortality. Nonetheless, becaus
Autor:
Rudy Chapusette, Laurence Dedeken, Phu-Quoc Le, Catherine Heijmans, Christine Devalck, Sophie Huybrechts, France Ziereisen, Laurence Hanssens, Malou Ngalula, Alina Ferster
Publikováno v:
Blood. 120:2107-2107
2107 [][1] The 6-minute walk test (6MWT) evaluates the sub-maximal functional exercise capacity and can be used together with the tricuspid regurgitant jet velocity (TRV) and pro-BNP to screen pulmonary hypertension in adults with sickle cell disease
Autor:
Matthew B. Siegel, Patrick J. Stiff, Aileen Go, Tulio E. Rodriguez, Brian Hess, Maria Theodorou, Michael Tallarico, Shams Bakhos, Scott E. Smith
Publikováno v:
Blood. 120:3102-3102
Abstract 3102 Identifying the optimal patients and timing for allogeneic hematopoietic stem cell transplant (HSCT) is an ongoing challenge for transplant centers that requires assessment of more than just the disease status and stage. Pre-existing co
Autor:
Lidia Mongay, John V. Reynolds, Hagop M. Kantarjian, David Joske, Luis Meillon, Jorge E. Cortes, Dong-Wook Kim, Ricardo Pasquini, Timothy P. Hughes
Publikováno v:
ResearcherID
Abstract 2292 Background: This ongoing international, prospective registry provides 5-year longitudinal data on diagnosis methods, management strategies, and outcomes for CML patients (pts) worldwide. Deviations from published disease management reco